Singapore updates tax guide for pharmaceutical manufacturing industry covering R&D and IP

The Singapore government today released an updated e-Tax guide for the pharmaceutical manufacturing industry addressing the tax treatment of research and development and intellectual property.

 

 Specifically, the guidance discusses:

 

 (a) The deduction of research and development expenditure under s

sections 14D and 14DA of the Income Tax Act (“ITA”);

(b) Writing down allowances under section 19B of the ITA;

(c) Income from provision of R&D services;

(d) Deduction of royalty payments and withholding tax implications.